Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory
Sonia Ndeupen, Zhen Qin, Sonya Jacobsen, et al.
iScience (2021) Vol. 24, Iss. 12, pp. 103479-103479
Open Access | Times Cited: 379

Showing 1-25 of 379 citing articles:

New‐onset autoimmune phenomena post‐COVID‐19 vaccination
Yue Chen, Zhiwei Xu, Peng Wang, et al.
Immunology (2021) Vol. 165, Iss. 4, pp. 386-401
Open Access | Times Cited: 423
IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines
Siri Tähtinen, Ann-Jay Tong, Patricia Himmels, et al.
Nature Immunology (2022) Vol. 23, Iss. 4, pp. 532-542
Open Access | Times Cited: 325
Unlocking the promise of mRNA therapeutics
Eduarde Rohner, Ran Yang, Kylie S. Foo, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 11, pp. 1586-1600
Open Access | Times Cited: 289
Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses
Tianyang Mao, Benjamin Israelow, Mario A. Peña-Hernández, et al.
Science (2022) Vol. 378, Iss. 6622
Open Access | Times Cited: 238
Innate immune mechanisms of mRNA vaccines
R Verbeke, Michael J. Hogan, Karin Loré, et al.
Immunity (2022) Vol. 55, Iss. 11, pp. 1993-2005
Open Access | Times Cited: 215
Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis
Ioannis P. Trougakos, Evangelos Terpos, Harry Alexopoulos, et al.
Trends in Molecular Medicine (2022) Vol. 28, Iss. 7, pp. 542-554
Open Access | Times Cited: 196
Lipid nanoparticles in the development of mRNA vaccines for COVID-19
Barnabas Wilson, K. Geetha
Journal of Drug Delivery Science and Technology (2022) Vol. 74, pp. 103553-103553
Open Access | Times Cited: 132
Targeting cancer with mRNA–lipid nanoparticles: key considerations and future prospects
Edo Kon, Nitay Ad‐El, Inbal Hazan‐Halevy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 11, pp. 739-754
Open Access | Times Cited: 127
Recent advances in mRNA-LNP therapeutics: immunological and pharmacological aspects
Seyed Hossein Kiaie, Naime Majidi Zolbanin, Armin Ahmadi, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 117
Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities
Majed Ghattas, Garima Dwivedi, Marc Lavertu, et al.
Vaccines (2021) Vol. 9, Iss. 12, pp. 1490-1490
Open Access | Times Cited: 113
Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines
János Szebeni, Gert Storm, Julia Y. Ljubimova, et al.
Nature Nanotechnology (2022) Vol. 17, Iss. 4, pp. 337-346
Open Access | Times Cited: 110
Exosome-mediated mRNA delivery in vivo is safe and can be used to induce SARS-CoV-2 immunity
Shang Jui Tsai, Nadia A. Atai, Mafalda Cacciottolo, et al.
Journal of Biological Chemistry (2021) Vol. 297, Iss. 5, pp. 101266-101266
Open Access | Times Cited: 109
Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of in vivo imaging
Han Na Jung, Seok‐Yong Lee, Somin Lee, et al.
Theranostics (2022) Vol. 12, Iss. 17, pp. 7509-7531
Open Access | Times Cited: 108
Advances in Circular RNA and Its Applications
Xian Zhao, Youxiu Zhong, Xudong Wang, et al.
International Journal of Medical Sciences (2022) Vol. 19, Iss. 6, pp. 975-985
Open Access | Times Cited: 107
Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications
Michaela Jeong, Yeji Lee, Jeongeun Park, et al.
Advanced Drug Delivery Reviews (2023) Vol. 200, pp. 114990-114990
Closed Access | Times Cited: 87
mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy
Zhuoya Deng, Yuying Tian, Jianxun Song, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 82
Intra-articular drug delivery systems for osteoarthritis therapy: shifting from sustained release to enhancing penetration into cartilage
Huirong Huang, Zijian Lou, Shimin Zheng, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 767-791
Open Access | Times Cited: 76
Leveraging self-assembled nanobiomaterials for improved cancer immunotherapy
Michael P. Vincent, Justin O. Navidzadeh, Sharan Bobbala, et al.
Cancer Cell (2022) Vol. 40, Iss. 3, pp. 255-276
Open Access | Times Cited: 73
Quality by Design for enabling RNA platform production processes
Simon Daniel, Zoltán Kis, Cleo Kontoravdi, et al.
Trends in biotechnology (2022) Vol. 40, Iss. 10, pp. 1213-1228
Open Access | Times Cited: 73
Understanding the Role and Impact of Poly (Ethylene Glycol) (PEG) on Nanoparticle Formulation: Implications for COVID-19 Vaccines
Esperanza Padín-González, Pearl Lancaster, Massimo Bottini, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 71
Polymer nanoparticles deliver mRNA to the lung for mucosal vaccination
Alexandra Suberi, Molly K. Grun, Tianyang Mao, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 709
Open Access | Times Cited: 70
Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA
Bowen Li, Allen Yujie Jiang, Idris Raji, et al.
Nature Biomedical Engineering (2023)
Closed Access | Times Cited: 68
Recent Progress of Lipid Nanoparticles-Based Lipophilic Drug Delivery: Focus on Surface Modifications
Yoseph Seo, Hayeon Lim, Hyunjun Park, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 772-772
Open Access | Times Cited: 67
Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability
Lizhou Zhang, Kunal R. More, Amrita Ojha, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 67
Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals
Jennifer Connors, David Joyner, Nathan Mege, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 53
Page 1 - Next Page

Scroll to top